New Delhi, Feb 7 (IANS) Health industry leaders on Saturday welcomed the interim agreement on the bilateral trade deal between India and the US.As part of the interim framework, the US will slash reciprocal tariffs on Indian goods to 18 per cent. The US will also remove the reciprocal tariff on generic pharmaceuticals, among other sectors like gems and diamonds, and aircraft parts. Although full details are yet to emerge, the interim India-US trade deal framework indicates that India has receive…
Latest Rajiv Nath News & Updates
New Delhi, Feb 3 (IANS) The trade deal between India and the US is a game-changer for the Indian MedTech and pharma sectors, said industry experts on Tuesday.In a historic move, the US has announced a reduction in tariffs on Indian exports to 18 per cent from 50 per cent, which is a constructive development for the India-US trade relations.The US is India’s largest export destination, accounting for about 20 per cent of total exports.The Association of Indian Medical Devices (AiMeD), hailed th…
New Delhi, Feb 1 (IANS) Industry experts on Sunday hailed the Union Budget 2026’s push to the biopharma sector, clinical trials, along with its thrust to the medical tourism and Ayurveda.The Union Budget 2026-27, presented by Finance Minister Nirmala Sitharaman in Parliament, proposed the Biopharma Shakti (Strategy for Healthcare Advancement through Knowledge, Technology, and Innovation) scheme.The scheme, with an outlay of Rs 10,000 crores over the next five years, aims to develop India as a …
New Delhi, Jan 22 (IANS) Ahead of the Union Budget 2026-27, industry experts on Thursday urged the government to boost the health spending, and grant GST exemption on lifesaving equipment and vaccines, especially for thalassemia and cancer patients.The Union Budget will be presented by the Finance Minister Nirmala Sitharaman on February 1 at 11 am.Citing the rising burden of non‑communicable diseases and cancers in the country, the expert urged the government to invest more deeply in public he…